Genetic vaccines directed against bacterial exotoxins
US7687613B2 · kind B2 · utility
0Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2003 |
| Grant date | Mar 30, 2010 |
| Priority date | — |
| Expiry date | Nov 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a gene transfer vector comprising a humanized nucleic acid sequence encoding an immunogenic portion of one or more exotoxins of Bacillus anthracis and a heterologous sorting signal. The invention also provides a method of producing an immune response against Bacillus anthracis in a host comprising administering to the host the gene transfer vector.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.